Stock CAJ CAPITOL HEALTH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Capitol Health Limited

Equities

CAJ

AU000000CAJ0

Healthcare Facilities & Services

Market Closed - Australian S.E.
Other stock markets
 02:10:44 2024-04-26 am EDT 		5-day change 1st Jan Change
0.24 AUD 0.00% Intraday chart for Capitol Health Limited +4.35% +2.13%
Feb. 28 Transcript : Capitol Health Limited, H1 2024 Earnings Call, Feb 29, 2024
Feb. 28 Capitol Health Posts 20% Rise in H1 FY24 Revenue, Returns to Profit MT

Valuation

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 176.7 235.2 380.4 291.2 286.4 255.7 - -
Enterprise Value (EV) 1 210.2 300.5 452.7 296.7 339.9 380.8 378.4 369.6
P/E ratio 6.87 x 245 x 32.7 x 27.7 x -25 x 29.7 x 18 x 15.3 x
Yield 4.35% 4.08% 2.7% 3.57% 3.7% 4.03% 4.13% 4.86%
Capitalization / Revenue 1.18 x 1.53 x 2.14 x 1.58 x 1.37 x 1.07 x 1.01 x 0.96 x
EV / Revenue 1.41 x 1.95 x 2.54 x 1.61 x 1.62 x 1.6 x 1.5 x 1.39 x
EV / EBITDA 8.09 x 10.8 x 9.43 x 7.21 x 8.46 x 7.86 x 6.95 x 6.32 x
EV / FCF 58.4 x 13.2 x 13.6 x 15.1 x 16.6 x 47.6 x 25.2 x 26.4 x
FCF Yield 1.71% 7.6% 7.34% 6.64% 6.03% 2.1% 3.96% 3.79%
Price to Book 1.53 x 1.74 x 2.6 x 1.91 x 2.09 x 1.92 x 1.85 x 1.76 x
Nbr of stocks (in thousands) 768,445 960,100 1,028,098 1,039,870 1,060,564 1,065,437 - -
Reference price 2 0.2300 0.2450 0.3700 0.2800 0.2700 0.2400 0.2400 0.2400
Announcement Date 8/27/19 8/26/20 8/25/21 8/24/22 8/23/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 149.2 153.8 178 184.2 209.6 238.5 252.8 266
EBITDA 1 26 27.77 48.02 41.13 40.2 48.46 54.45 58.52
EBIT 1 17.1 1.748 26.63 20.07 15.5 21.31 26.68 30.77
Operating Margin 11.46% 1.14% 14.96% 10.9% 7.4% 8.94% 10.55% 11.57%
Earnings before Tax (EBT) - 2.163 - 15.95 -10.07 - 21.19 25.46
Net income 1 27.53 0.865 11.92 10.73 -11.39 8.395 14.08 16.76
Net margin 18.45% 0.56% 6.7% 5.83% -5.44% 3.52% 5.57% 6.3%
EPS 2 0.0335 0.001000 0.0113 0.0101 -0.0108 0.008090 0.0133 0.0157
Free Cash Flow 1 3.6 22.84 33.25 19.69 20.5 8 15 14
FCF margin 2.41% 14.85% 18.68% 10.69% 9.78% 3.35% 5.93% 5.26%
FCF Conversion (EBITDA) 13.85% 82.25% 69.24% 47.88% 50.98% 16.51% 27.55% 23.92%
FCF Conversion (Net income) 13.07% 2,640.92% 278.96% 183.49% - 95.3% 106.53% 83.52%
Dividend per Share 2 0.0100 0.0100 0.0100 0.0100 0.0100 0.009670 0.009920 0.0117
Announcement Date 8/27/19 8/26/20 8/25/21 8/24/22 8/23/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2
Net sales 1 85.3 92.69 94.83 89.33 98.07 111.5
EBITDA 1 - 21.47 - 18.93 19.7 20.5
EBIT 1 - 10.14 - 7.931 8.038 7.462
Operating Margin - 10.94% - 8.88% 8.2% 6.69%
Earnings before Tax (EBT) - 8.575 - - - -
Net income 1 - 5.645 - 2.736 -15.18 3.782
Net margin - 6.09% - 3.06% -15.47% 3.39%
EPS 0.005900 0.005400 0.007500 0.002600 - -
Dividend per Share 2 - 0.005000 - 0.005000 0.005000 0.005000
Announcement Date 2/23/21 8/25/21 2/23/22 8/24/22 2/22/23 8/23/23
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 33.5 65.3 72.3 5.5 53.6 125 123 114
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.288 x 2.351 x 1.506 x 0.1338 x 1.333 x 2.581 x 2.254 x 1.947 x
Free Cash Flow 1 3.6 22.8 33.2 19.7 20.5 8 15 14
ROE (net income / shareholders' equity) 6.99% 2.52% 8.23% 7.74% 6.38% 8.08% 10.8% 12.5%
ROA (Net income/ Total Assets) 4.79% 1.44% 4.4% 4.2% 3.17% 5.41% 6.5% 7.61%
Assets 1 574.2 59.88 271 255.6 -359.7 155.2 216.6 220.4
Book Value Per Share 2 0.1500 0.1400 0.1400 0.1500 0.1300 0.1200 0.1300 0.1400
Cash Flow per Share 2 0.0200 0.0400 0.0400 0.0300 0.0400 0.0300 0.0400 0.0400
Capex 1 14.7 12.2 7.64 13.2 19 20.6 18.7 18.7
Capex / Sales 9.85% 7.91% 4.29% 7.15% 9.04% 8.62% 7.39% 7.02%
Announcement Date 8/27/19 8/26/20 8/25/21 8/24/22 8/23/23 - - -
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Capitol Health Limited

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
0.24 AUD
Average target price
0.2836 AUD
Spread / Average Target
+18.15%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
CAPITOL HEALTH LIMITED Stock Capitol Health Limited
+2.13% 167M
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-17.89% 8.25B
RADNET, INC. Stock RadNet, Inc.
+39.20% 3.57B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-39.11% 2.46B
SYNLAB AG Stock SYNLAB AG
-8.06% 2.46B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-7.35% 2.38B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-12.61% 1.81B
FLEURY S.A. Stock Fleury S.A.
-19.01% 1.55B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-40.66% 1.21B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+7.56% 1.11B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. CAJ Stock
  4. Financials Capitol Health Limited